Drug trial aims to stop dangerous bleeding after kidney tests
NCT ID NCT06622187
Summary
This study is testing whether a medication called desmopressin can safely prevent bleeding in kidney transplant patients who need a biopsy. Researchers are comparing the drug to a placebo (saltwater) given right before the procedure. The goal is to see if the drug reduces both minor and serious bleeding events after the biopsy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90410000, Brazil
Conditions
Explore the condition pages connected to this study.